Acetylcholinesterase inhibitors may improve efficacy and reduce adverse effects of tricyclic antidepressants for depression

被引：0
作者：
Niederhofer, Helmut [1 ]
机构：
[1] Reg Hosp Bolzano, Dept Pediat, Bolzano, Italy
来源：
DRUGS & AGING | 2008年 / 25卷 / 08期
关键词：
D O I：
10.2165/00002512-200825080-00008
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：715 / 715
页数：1
相关论文
共 7 条
[1]   Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability [J].
Anderson, IM .
JOURNAL OF AFFECTIVE DISORDERS, 2000, 58 (01) :19-36
[2]   Factors associated with complex visual hallucinations during antidepressant treatment [J].
Cancelli, I ;
Marcon, G ;
Balestrieri, M .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 (08) :577-584
[3]   A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurological disorders [J].
Figiel, Gary ;
Sadowsk, Carl .
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (01) :157-166
[4]  
Hay F, 2004, Rev Med Brux, V25, pA315
[5]   Rivastigmine in the treatment of Alzheimer's disease: an update [J].
Onor, Maria Luisa ;
Trevisiol, Marianna ;
Aguglia, Eugenio .
CLINICAL INTERVENTIONS IN AGING, 2007, 2 (01) :17-32
[6]   Alternatives to atypical antipsychotics for the management of dementia-related agitation [J].
Passmore, Michael J. ;
Gardner, David M. ;
Polak, Yvette ;
Rabheru, Kiran .
DRUGS & AGING, 2008, 25 (05) :381-398
[7]  
Wender PH, 2001, ANN NY ACAD SCI, V931, P1
1